Thick IPO Blotter for Week of June 17

Whirly lollipop on orange background.

It’s hard to believe there are 13 IPO transactions schedule to price in the next few days. But here they are. So far Foresight Energy (FELP), Viper Energy (VNOM), and Markit (MRKT) are being whispered about as being the best ones. We’ll be finding out soon as about 1/2 are scheduled to price tonight and the rest Wednesday night.

2014-06-17_09-49-42

Ambrx is developing a pipeline of protein therapeutic product candidates that include antibody drug conjugates for the treatment of breast and other types of cancer. The company has collaborations with Bristol-Myers Squibb Company, Merck Sharp & Dohme Corp., Eli Lilly and Company, Agensys, Inc., Zhejiang Medicine Co., Ltd., and Zhejiang Hisun Pharmaceutical Co., Ltd. Ambrx, Inc. was founded in 2003 and is based in La Jolla, California.

Ardelyx is developing small molecule therapeutics to treat cardio-renal, gastrointestinal (GI), and metabolic diseases. Ardelyx has a collaboration partnership agreement with AstraZeneca AB for the development and commercialization of tenapanor. Ardelyx, Inc. was founded in 2007 and is headquartered in Fremont, California.

Century Communities is a homebuilder in metropolitan markets in Colorado. The company also operates in the greater Austin and San Antonio, Texas and Las Vegas, and Nevada metropolitan areas. As of April 1, 2014, it owned and controlled approximately 99 communities consisted of 10,095 lots. Century Communities, Inc. was founded in 2000 and is based in Greenwood Village, Colorado.

Eclipse Resources Corporation acquires and develops oil and natural gas properties in the Appalachian Basin. As of March 31, 2014, it had acreage of approximately 227,230 net acres in Eastern Ohio. The company’s estimated proved reserves consisted of 109.6 billion cubic feet of natural gas equivalent. Eclipse Resources Corporation was founded in 2011 and is headquartered in State College, Pennsylvania.

Foresight Energy LLC offers coal mining, production, transportation, and distribution. It provides thermal, metallurgical, and bituminous coal. The company is based in St. Louis, Missouri. Foresight Energy LLC operates as a subsidiary of Foresight Energy Partners LP.

GoPro develops hardware and software solutions for capturing, managing, sharing, and enjoying engaging video content. GoPro sells its products through retailers and wholesale distributors, as well as through its Website in the United States and internationally. GoPro was founded in 2004 and is headquartered in San Mateo, California.

KineMed is developing a proprietary biomarker platform technology for drug development, prescription, and non-prescription medical diagnostics and the pairing of drugs with diagnostic biomarker tests. It plans to commercialize biomarkers in the areas of muscle biology, fibrotic diseases, neurodegenerative diseases, cardiometabolic diseases, skin care, and cancer. The company was founded in 2001 and is based in Emeryville, California.

Kite Pharma is working on novel cancer immunotherapy products. The company has collaboration agreement with the Surgery Branch of the National Cancer Institute. Kite Pharma, Inc. was founded in 2009 and is headquartered in Santa Monica, California.

Markit focuses on providing financial information services to enhance transparency, reduce risk, and improve operational efficiency in the financial markets. The company was incorporated in 2003 and is headquartered in London, the United Kingdom.

Minerva Neurosciences develops drug candidates for the treatment of central nervous system diseases like schizophrenia, depression, insomnia, and Parkinson’s disease. Minerva Neurosciences has a co-development and license agreement with Janssen Pharmaceutica, N.V.  The company was founded in 2007 and is headquartered in Cambridge, Massachusetts.

Parnell Pharmaceuticals develops animal health solutions. It operates in four segments: Companion Animal, Production Animal – U.S. & Rest of World, and Manufacturing Operations. The company was founded in 1986 and is headquartered in Alexandria, Australia.

Syndax Pharmaceuticals is an oncology-based drug developer aiming at cancers, such as breast cancer and lung cancer, as well as other indications comprising solid tumors and hematological malignancies. The company has a collaborative research and development agreement with the National Cancer Institute. Syndax Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Waltham, Massachusetts.

Viper Energy Partners LP owns, acquires, exploits, and develops oil and natural gas properties in North America. The company focuses on developing mineral interests covering approximately 14,804 gross acres in the Permian Basin in West Texas. As of December 31, 2013, its estimated proved oil and natural gas reserves consisted of 10,270 barrels of crude oil equivalent. Viper Energy Partners GP LLC operates as the general partner of the company. Viper Energy Partners LP was founded in 2013 and is based in Midland, Texas.

Zafgen is devloping drugs for patients suffering from obesity and obesity-related disorders. Zafgen, Inc. was founded in 2005 and is headquartered in Cambridge, Massachusetts.

ZS Pharma is developing non-absorbed drugs to treat renal, cardiovascular, liver, and metabolic diseases. The company’s proprietary zirconium silicate technology creates ion traps that could reduce toxic levels of specific electrolytes without disturbing the balance of other electrolytes. It is developing ZS-9, insoluble non-absorbed zirconium silicate that is in Phase III development for the treatment of hyperkalemia. The company was founded in 2008 and is headquartered in Coppell, Texas.

Leave a Comment